FEMY — Femasys Inc.
$1.50-3.85%
Last close: · regular session
After-hours $1.52 +1.66% ·
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for FEMY in the TickerWise workspace.
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
Company profile
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: US
- Exchange: NASDAQ
- Employees: 69
- Website: https://www.femasys.com
Latest SEC filings for FEMY
Latest FEMY news
- Femasys Partners with SandsRx Pharmacy to Support FemaSeed® Fertility Portfolio Launch to OB/GYNs Read article
- Femasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control Read article
- Femasys: Launch Is Funded. If The Sales Force Delivers, Then The Company Is In Tall Cotton. Read article
- Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.